Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion
- 1 June 1974
- journal article
- clinical trial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 15 (6) , 551-555
- https://doi.org/10.1002/cpt1974156551
Abstract
The effect of a new antidysrhythmic drug, disopyramide, was tested in a double‐blind clinical trial in 52 patients undergoing electroconversion of atrial fibrillation. During a 3 month follow‐up, the number of patients remaining in sinus rhythm after successful electroconversion was higher (p < 0.05) in the disopyramide group (72%) than in the placebo group (30%).Keywords
This publication has 0 references indexed in Scilit: